Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - asciminibum - compresse rivestite con film - asciminibum 20 mg ut asciminibi hydrochloridum 21.62 mg, lactosum monohydricum 43.11 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), e 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, e 172 (flavum), e 172 (rubrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.47 mg. - behandlung von erwachsenen patienten mit philadelphia-chromosom-positiver chronisch-myeloischer leukämie (ph+ cml) in der chronischen phase (cp) - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - asciminibum - compresse rivestite con film - asciminibum 40 mg ut asciminibi hydrochloridum 43.24 mg, lactosum monohydricum 86.22 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), e 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, e 172 (rubrum), e 172 (nigrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.93 mg. - behandlung von erwachsenen patienten mit philadelphia-chromosom-positiver chronisch-myeloischer leukämie (ph+ cml) in der chronischen phase (cp) - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - asciminib hydrochloride - leucemia, myelogenous, chronic, bcr-abl positive - agenti antineoplastici - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 1 mg, lactosum monohydricum 32 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.087 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 1.12 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 3 mg, lactosum monohydricum 96 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.262 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 3.36 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 5 mg, lactosum monohydricum 160 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.437 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 5.6 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 7 mg, lactosum monohydricum 224 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.611 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 7.84 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - axitinibum - compresse rivestite con film - axitinibum 1 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.09 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, e 171, e 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 33.12 mg. - carcinoma a cellule renali - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - axitinibum - compresse rivestite con film - axitinibum 3 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.27 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, e 171, e 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 99.36 mg. - carcinoma a cellule renali - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - axitinibum - compresse rivestite con film - axitinibum 5 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.46 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, e 171, e 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 165.60 mg. - carcinoma a cellule renali - synthetika